ROS1 and laryngotracheoesophageal cleft: In this study, we aimed to investigate the mutational landscape of LC and LCNEC tumors using a panel of 26 well-established oncogenes and tumor suppressor genes in combination with ALK, RET, and ROS1 gene fusion analysis and copy number analysis of targeted genes.